Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 9/25/2008 First Published: 11/29/2007


1.		Phase I/II Study of Adoptive Immunotherapy Utilizing Activated Marrow Infiltrating Lymphocytes in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation for Newly Diagnosed Stage II or III Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				JHOC-J0770 J0770, NCT00566098

Last Modified: 10/31/2008 First Published: 11/1/1999


2.		Phase II Study of Adoptive Transfer of Cloned Lymphocytes With Interleukin-2 After Cyclophosphamide and Fludarabine in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				NCI-99-C-0158 NCI-T99-0078, T99-0078, NCT00019942


3.		Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				18 and over				Other				CD-2007-01 NCT00610389

Last Modified: 10/9/2008 First Published: 2/21/2007


4.		Phase I Pilot Study of Adoptive Cell Therapy Comprising Tumor-Derived Lymphocytes in Patients With Persistent or Recurrent B-Cell Lymphoid Malignancies After Prior Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 to 75				NCI				NCI-07-C-0064 NCT00445666

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute